Source: Clinical Science. Unidades: FCFRP, FMRP
Subjects: ACETILCOLINA (FARMACOLOGIA), AORTA TORÁCICA (EFEITOS DE DROGAS), ENDOTÉLIO VASCULAR, ÓXIDO NÍTRICO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
NEVES, Karla Bianca et al. Chemerin reduces vascular nitric oxide/cGMP signalling in rat aorta: a link to vascular dysfunction in obesity?. Clinical Science, v. 127, n. 2, p. 111-122, 2014Tradução . . Disponível em: https://doi.org/10.1042/CS20130286. Acesso em: 18 ago. 2024.APA
Neves, K. B., Lobato, N. S., Lopes, R. A. M., Filgueira, F. P., Zanotto, C. Z., Oliveira, A. M. de, & Tostes, R. de C. A. (2014). Chemerin reduces vascular nitric oxide/cGMP signalling in rat aorta: a link to vascular dysfunction in obesity? Clinical Science, 127( 2), 111-122. doi:10.1042/CS20130286NLM
Neves KB, Lobato NS, Lopes RAM, Filgueira FP, Zanotto CZ, Oliveira AM de, Tostes R de CA. Chemerin reduces vascular nitric oxide/cGMP signalling in rat aorta: a link to vascular dysfunction in obesity? [Internet]. Clinical Science. 2014 ; 127( 2): 111-122.[citado 2024 ago. 18 ] Available from: https://doi.org/10.1042/CS20130286Vancouver
Neves KB, Lobato NS, Lopes RAM, Filgueira FP, Zanotto CZ, Oliveira AM de, Tostes R de CA. Chemerin reduces vascular nitric oxide/cGMP signalling in rat aorta: a link to vascular dysfunction in obesity? [Internet]. Clinical Science. 2014 ; 127( 2): 111-122.[citado 2024 ago. 18 ] Available from: https://doi.org/10.1042/CS20130286